The end of the inversion: will pharma leave Ireland after tax rises?
Ireland recently agreed to a 15% minimum tax rate, which could have implications for the pharmaceutical companies based there.
By
Ireland
Latest in
Ireland
Endo International agrees to acquire BioSpecifics Technologies for $540m
Endo International has agreed to acquire BioSpecifics Technologies in a cash-based transaction valued at approximately $540m.
Roche acquires biotech firm Inflazome for $449m
Roche has completed a share purchase agreement to acquire Irish biotech firm Inflazome for an upfront payment of $449m (€380m).
Regeneron to create 400 jobs to support manufacturing in Ireland
Regeneron Pharmaceuticals has plans to add more than 400 new jobs t its Industrial Operations and Product Supply (IOPS) campus…
Allergan opens new biologics facility in Westport, Ireland
Biopharmaceutical company Allergan has opened a Biologics 2 facility at its Westport Campus in Mayo, Ireland to meet the demand…
Beyond Viagra Town: profiling the Irish pharma industry
The vast majority of the world’s supply of Viagra is manufactured by Pfizer in a small village in County Cork,…
By
Alkermes to acquire Rodin Therapeutics in $950m deal
Irish biopharmaceutical company Alkermes has agreed to buy US-based neuroscience-focused firm Rodin Therapeutics under a deal worth up to $950m.
Allergan shareholders approve $63bn Abbvie acquisition
The shareholders of Irish pharmaceutical company Allergan have approved the $63bn acquisition by Botox manufacturer Abbvie.